Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Lagged due to tariff concerns following the Liberation Day announcement, but underlying fundamentals and long-term outlook remain strong with expected margin mitigation by 2026.
— Eric Mintz, Christopher Sassouni, David Cavanaugh
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Merit Medical Systems Inc.
Merit Medical Systems delivers single-use medical devices and has successfully translated high single-digit revenue growth into stronger earnings through margin improvement efforts. Additionally, a newly...
Although Merit Medical reported solid organic revenue and EBITDA growth, the manager highlights tariff headwinds in China as a key challenge that led to a downward revision of 2025 EPS guidance. The company hopes...